AIIC AI Intelligence Centre

SOURCE-LINKED INTELLIGENCE

Monitor Multiple Sclerosis evolution using body fluids derive cell-free epigenomics

CORDIS · observation · Publication date unknown

ormative content of cfChromatin. The final phase of the project will include further integration of the generated cfChromatin data with several MS single-cell transcriptome and spatial data. Finally, machine learning will be used to test cfChromatin as a stage/treatment-specific biomarker in MS. Single-cell Neuro-immunology Multiple-Sclerosis Cell-free-DNA Precision-Medicine Diagnostic

Read original source ↗ Open in workspace

recordType
award
status
SIGNED
region
EU
value
222727.68
unit
EUR

Evidence & attribution

European Commission, CORDIS Horizon Europe project dataset. Metadata adapted.

License: CORDIS reuse policy

First collected: 2026-09-20T02:21:08.944Z. This is not the publication date.